Cefazolin in the treatment of bacterial pneumonia.
D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004361:Drug Tolerance; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D011014:Pneumonia / Q000188:drug therapy*; D013210:Staphylococcus; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles